Probenecid, 98%, Thermo Scientific Chemicals
Probenecid, 98%, Thermo Scientific Chemicals
Probenecid, 98%, Thermo Scientific Chemicals
Probenecid, 98%, Thermo Scientific Chemicals
Thermo Scientific Chemicals

Probenecid, 98%, Thermo Scientific Chemicals

CAS: 57-66-9 | C13H19NO4S | 285.36 g/mol
Have Questions?
Change viewbuttonViewtableView
Quantity:
10 g
2.5 g
Catalog number ALFB20010.09
View Price:Sign in to see your account pricing. Need an account? Register with us today.
Quantity:
10 g
Request bulk or custom format
Specifications
Chemical Name or MaterialProbenecid
CAS57-66-9
Health Hazard 1H302-H315-H319-H335
Health Hazard 2GHS H Statement
H301-H315-H319-H335
Toxic if swallowed.
Causes skin irritation.
Causes serious eye irritation.
May cause respiratory irritation.
Health Hazard 3P261-P264b-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P312-P330-P332+P313-P362-P501c
View more
It is a uricosuric drug, that is, it increases uric acid excretion in the urine. It is primarily used in treating gout and hyperuricemia. Probenecid was developed as an alternative to caronamide to competitively inhibit renal excretion of some drugs, thereby increasing their plasma concentration and prolonging their effects.

This Thermo Scientific Chemicals brand product was originally part of the Alfa Aesar product portfolio. Some documentation and label information may refer to the legacy brand. The original Alfa Aesar product / item code or SKU reference has not changed as a part of the brand transition to Thermo Scientific Chemicals.

Solubility
Soluble in water (partly miscible), solutions of alkali hydroxides,, ethanol (100 mM), acetone, chloroform, sodium hydroxide (1 M), DMSO (100 mM), methanol, dilute acids (practically insoluble), dilute alkalies, and ether (slightly soluble).

Notes
Store away from oxidizing agents. Keep the container tightly closed and place it in a cool, dry and well ventilated condition.
RUO – Research Use Only

General References:

  1. Campos-Arroyo D, et al. Probenecid is a chemosensitizer in cancer cell lines.Cancer chemotherapy and pharmacology.1992,69(2), 495-504.
  2. Robbins N, et al. The history and future of probenecid.Cardiovascular toxicology.2012,12(1), 1-9.